Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Trulicity weight loss cost?Spironolactone amneal?Ingenus leucovorin ingredients?Ubrogepant patent us?Viatris levothyroxine?
See the DrugPatentWatch profile for Erleada
Erleada is the brand name for the drug apalutamide.
Apalutamide is used for certain cases of prostate cancer, including non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer (depending on the specific indication and approval/labeling).
If a generic is available, it would generally be sold under the generic name apalutamide (not “Erleada”). Exact availability depends on the market and regulatory status.
For the latest on generic-entry status and patent information tied to Erleada/apalutamide, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/ Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Erleada :